Portolan Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$12.9M |
| 2 |
Marathon Petroleum
MPC
|
+$11.9M |
| 3 |
Exelixis
EXEL
|
+$11.3M |
| 4 |
LivePerson
LPSN
|
+$11M |
| 5 |
Turning Point Brands
TPB
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAND
Bandwidth Inc
BAND
|
+$22.4M |
| 2 |
Nutanix
NTNX
|
+$13.9M |
| 3 |
TWOU
2U Inc
TWOU
|
+$10.9M |
| 4 |
Stoneridge
SRI
|
+$10.5M |
| 5 |
GPOR
Gulfport Energy Corp.
GPOR
|
+$9.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.39% |
| 2 | Communication Services | 11.87% |
| 3 | Energy | 10.45% |
| 4 | Consumer Staples | 9.57% |
| 5 | Consumer Discretionary | 9.37% |
Similar funds
Portolan Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Portolan Capital Management held 99 positions worth $930M, down 4.4% from $972M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Portolan Capital Management withdrew a net $43.4M in Q2 2019, closing 11 positions and reducing 40 holdings. Its most notable exit was Evolent Health, an estimated $9.06M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 41% a quarter earlier, followed by Communication Services and Energy.
Against the trend, Portolan Capital Management opened a new position in Nu Skin worth $12.5M.
- Portolan Capital Management's largest Q2 2019 buy was Nu Skin: 253,347 shares worth $12.5M.
- Portolan Capital Management added most to Marathon Petroleum in Q2 2019, an estimated $11.9M increase.
- Portolan Capital Management's biggest Q2 2019 reduction was Bandwidth Inc, cutting an estimated $22.4M.
- Portolan Capital Management fully exited Evolent Health in Q2 2019, selling an estimated $9.06M.
- Portolan Capital Management's ten largest holdings make up 37% of its $930M portfolio in Q2 2019.
- Portolan Capital Management opened 12 new positions and closed 11 in Q2 2019.
- Portolan Capital Management's portfolio value fell 4.4% quarter-over-quarter to $930M.
Based on Portolan Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.